HYPERION DEFI, INC.

Profile

Company Names

HYPERION DEFI, INC.
EYENOVIA, INC.

Addresses

23461 SOUTH POINTE DRIVE, SUITE 390, LAGUNA HILLS, CA 92653

295 MADISON AVENUE,, SUITE 2400, NEW YORK, NY 10017

8748 TECHNOLOGY WAY, RENO, NV 89521

400 N ASHLEY DRIVE, SUITE 2150, TAMPA, FL 33602

Phone Numbers

833-393-6684
917-289-1117
813-766-9539

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$66,026,336.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-06-20 
$49,999,999.00 
$49,999,999.00 
$0.00 
Equity 
3
2020-03-24 
$5,985,000.00 
$5,985,000.00 
$0.00 
Equity 
2
2017-07-07 
$6,000,000.00 
$20,000,000.00 
$14,000,000.00 
Equity 
1
2016-07-19 
$4,041,337.00 
$8,000,000.00 
$3,958,663.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BARRY 
 
BUTLER 
EXECUTIVE OFFICER
SIRION HOLDINGS, INC.   |  SIRION HOLDINGS, INC.   |  KUROBE PHARMACEUTICALS, INC.   |  EYENOVIA, INC.   |  BETALIQ INC   |  SUBIOMED, INC.
FRED 
 
ESHELMAN 
DIRECTOR
XORI CORP   |  CORINTHIAN OPHTHALMIC, INC.   |  MERYX INC.   |  NEOANTIGENICS, INC.   |  DIGNIFY THERAPEUTICS, LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  ASEPTICYS, INC.   |  EYENOVIA, INC.   |  ASEPTICYS, LLC
FREDRIC 
 
ESHELMAN 
DIRECTOR
MEDIKIDZ, INC.   |  EYENOVIA, INC.
JOHN 
 
GANDOLFO 
EXECUTIVE OFFICER
BACTERIN INTERNATIONAL HOLDINGS, INC.   |  EYENOVIA, INC.   |  ODYSSEY GROUP INTERNATIONAL, INC.   |  ODYSSEY HEALTH, INC.
MICHAEL 
 
GELTZEILER 
DIRECTOR
HYPERION DEFI, INC.
TSONTCHO 
 
IANCHULEV 
EXECUTIVE OFFICER, DIRECTOR
SAFEOP SURGICAL, INC.   |  TRANSCEND MEDICAL INC   |  EYENOVIA, INC.   |  IANTECH, INC.   |  IANTREK, INC.   |  KYS VISION, INC.
RACHEL 
 
JACOBSON 
DIRECTOR
HYPERION DEFI, INC.   |  PEDAL WORKS, INC.
HYUNSU 
 
JUNG 
EXECUTIVE OFFICER, DIRECTOR
HYPERION DEFI, INC.
CURT 
 
LABELLE 
DIRECTOR, EXECUTIVE OFFICER
SAFEOP SURGICAL, INC.   |  EXAGEN DIAGNOSTICS INC   |  KUROBE PHARMACEUTICALS, INC.   |  EYENOVIA, INC.   |  INPRESS TECHNOLOGIES, INC.   |  REVELATION BIOSCIENCES, INC   |  OPHIREX, INC.   |  CXL OPHTHALMICS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  RESOLUTE RESOURCES LTD./CAN   |  NOVOCUFF, INC.
KENNETH 
 
LEE 
DIRECTOR
BRIDGEHAMPTON LONG EQUITY FUND LLC   |  BANCAFFILIATED INC   |  VANGOGH IMAGING, INC.   |  TOWNSEND-MCDOWELL DURHAM REIT LLC   |  EYENOVIA, INC.   |  BAY VIEW PARTNERS AHF I, LLC   |  MHP AFFORDABLE HOUSING FUND I, LLC   |  SONDR, INC.
ERNEST 
 
MARIO 
DIRECTOR
AVID RADIOPHARMACEUTICALS, INC.   |  CAPNIA, INC.   |  TAXIS PHARMACEUTICALS INC.   |  PENINSULA SKINCARE LABS, INC.   |  CORINTHIAN OPHTHALMIC, INC.   |  TONIX PHARMACEUTICALS HOLDING CORP.   |  XENOPORT INC   |  KINDRED BIOSCIENCES, INC.   |  DELPOR, INC.   |  ORBUS THERAPEUTICS, INC.   |  EYENOVIA, INC.   |  SOLENO THERAPEUTICS INC   |  TAXIS PHARMACEUTICALS, INC.
CHARLES 
 
MATHER 
DIRECTOR
TONIX PHARMACEUTICALS HOLDING CORP.   |  EYENOVIA, INC.
MICHAEL 
 
ROWE 
EXECUTIVE OFFICER, DIRECTOR
SLC CAPITAL, LLC   |  MEDICALLY HOME GROUP ACQUISITION LLC   |  HYPERION DEFI, INC.
ELLEN 
 
STRAHLMAN 
DIRECTOR
HYPERION DEFI, INC.
ANTHONY 
 
SUN 
DIRECTOR
CENERX BIOPHARMA INC   |  NEOCONIX INC   |  BRIDGE PHARMACEUTICALS, INC.   |  LAVANTE INC   |  CANESTA INC   |  VERSARTIS, INC.   |  PACKET PHOTONICS, INC.   |  IMMUSOFT CORP   |  EYENOVIA, INC.   |  ALLOY THERAPEUTICS, INC.
SHUHEI 
 
YOSHIDA 
DIRECTOR
EYENOVIA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-07-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-06-20 
2020-04-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-03-24 
2017-08-14
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-07 
2016-08-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CHARDAN CAPITAL MARKETS, LLC
000120128
NONE
NONE
NATIONAL SECURITIES CORPORATION
7569